Serum concentration of interferon-α: A comparison between once-a-day and twice-a-day administration

International Journal of Clinical Pharmacology Research

Volumn 20, Issue 1-2, 2000, Pages 17-19

  Matsukawa, Y ^a   Nishinarita, S ^a   Horie, T ^a   Moriyama, M ^a   Tanaka, N ^a   Arakawa, Y ^a   Kamei, S ^a   Matsuura, M ^a   Kojima, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; LYMPHOBLAST INTERFERON; NAMALWA;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; MALE; TREATMENT OUTCOME; VIRUS INFECTION;

ADULT; ANTIVIRAL AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS C; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED;

EID: 0034509359     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Treatment of chronic non-A non-B hepatitis with recombinant of human alpha interferon
2. Efficacy of the therapy using twice-a-day interferon-β in the treatment of chronic hepatitis
3. Efficacy of combination therapy using twice-a-day interferon-β followed by IFN-α-2b in treatment for chronic hepatitis C
4. Efficacy and side effects of interferon-β twice a day administration for chronic active hepatitis C
5. Efficacy of treatment with IFN twice a day for chronic hepatitis C
6. Specific assays for cytokine production by T cells
7. Phase I study of recombinant human interferon-αA (Ro 22-8181) in patients with malignant tumors